Navigation Links
China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results

-- Quarterly Revenues Increase 62% to $11.7 million -- Quarterly Net Income Increases 76.5% to $4.2 million with EPS of $0.11

NEW YORK and HAIKOU, Hainan, China, May 2 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced its financial results for the first quarter of 2008.

First Quarter 2008 Highlights

-- Revenue increased 62%, to $11.7 million versus Q1 2007.

-- Net income was $4.2 million, up 76.5% versus Q1 2007.

-- Our existing products continue to generate strong sales during the

first quarter of 2008. Sales of Pusen OK have increased by $1 million,

Buflomedil Hydrochloride increased 198%, Gastrodin increased 70%, and

Cefaclor has increased 64% versus Q1 2007.

-- EPS was $0.11, up 57.1% versus Q1 2007.

Revenues for the first quarter of 2008 increased approximately 62% to $11.7 million, from $7.2 million in the first quarter of 2007. The significant increase in revenues was due to expanded production of the China Pharma's product portfolio supported by enhanced marketing efforts. The Company believes that this extraordinary growth should provide investors with confidence in China Pharma's ability to execute on their strategic marketing plan going forward. Therefore, the Company is reiterating that its 2008 full- year revenue growth is expected to exceed 40%.

Gross profit grew 76% to $5.8 million from $3.3 million in the first quarter of 2007. Gross margins were 49.6% compared to 45.6% recorded during the first quarter of 2008 and 2007 respectively. The growth of gross profit and the improved margins were primarily due to the substantial increase in revenues and the decrease in overall production expenses in the first quarter of 2008.

Operating expenses for the three months ended March 31, 2

SOURCE China Pharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
2. DuPont Partnering with China to Increase Farm Productivity
3. China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network
4. China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc.
5. Syngenta To Build Major Global Biotech Research Center in Beijing, China
6. American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance
7. China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier
8. CTDC Attends the Inauguration Ceremony of Thin Film A-Si Manufacturing Line in Changzhou, China
9. China Bio Energy Reports Fiscal 2007 Financial Results
10. Transgenomic Opens Pharmacogenomics Laboratory in China
11. China Pharma Holdings, Inc. Announces Record 2007 Year End Results
Post Your Comments:
(Date:7/22/2014)... (PRWEB) July 22, 2014 Quorum Review IRB, ... service for large clinical trials called Quick Step™ . ... designed to address the research industry’s need for seamless study ... service is available for studies planning 50 or more North ... combined planned North American site count of 80 or more. ...
(Date:7/22/2014)... SILVER SPRING, Md. , July 22, 2014 ... ) announced today that it will release its ... on Tuesday, July 29, 2014. United ... July 29, 2014, at 9:00 a.m. Eastern Time.  ... international callers dialing 1-970-315-0533.  A rebroadcast of the ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Holomic ... with the debut of its fluorescent immunoassay reader, ... Chemistry (AACC) meeting in Chicago, July 28-31, 2014. ... top versions, the HRDR-300 is a highly sensitive, ... to analyze fluorescent lateral flow immunoassays with high ...
(Date:7/22/2014)... Juli 2014 Qforma, ein führender Anbieter ... von Marcus Bergler zum General Manager ... europäischen kommerziellen Aktivitäten von Qforma bereits als Vice ... anschloss, war er in Positionen als VP Vertrieb ... Deutschland bei IMS Health und als Direktor bei ...
Breaking Biology Technology:Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 2Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 3Holomic to Debut HRDR-300 Fluorescent Immunoassay Reader at the AACC 2014 2Qforma gibt Schaffung des neuen Postens als General Manager in Europa bekannt 2
... Biotech Inc.,(TSX: ONC, NASDAQ: ONCY) (,Oncolytics,) reported ... group at The Institute of Cancer Research,London, ... characterizing immune,system responses to administration of intravenous ... paper, entitled "Characterization of the Adaptive and,Innate ...
... 17 OmniSonics Medical,Technologies, Inc., a developer of ... vascular disease, announced today that it has enrolled ... SONIC I is a prospective,multi-centered U.S. registry study ... undergoing percutaneous mechanical,thrombectomy of acute deep vein thrombosis ...
... ANGELES, March 17 Signalife, Inc. (Amex:,SGN - ... several formal,purchase and financial commitments with respect to ... These commitments have,come internationally, including in Japan, other ... Dr. Harmison, the Company,s President and CEO, ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial 2First Patient Enrolled in SONIC I Registry of OmniSonics Medical Technologies' OmniWave(TM) Endovascular System 2Signalife Sees Accretive Purchase and Financial Commitments 2
(Date:7/22/2014)... July 22, 2014, Cleveland: A type of immune ... diseases, such as Alzheimer,s disease and multiple sclerosis ... brain injury (TBI) and may slow the progression ... published today in the online journal Nature ... Bruce Trapp, PhD, Chair of the Department of ...
(Date:7/22/2014)... Not much is known about the the genus of ... after a new one was recently discovered in the ... city of Jaen. A description of it appears in ... ). , The new species, Conosimus ... Spanish hemipterologist, for his contributions to the taxonomy of ...
(Date:7/21/2014)... part of a multinational, collaborative effort, researchers from Canada,s ... identify over 100 locations in the human genome associated ... the largest genomic study published on any psychiatric disorder ... , point to biological mechanisms and pathways that may ... treating the disorder, which has seen little innovation in ...
Breaking Biology News(10 mins):Cleveland Clinic researchers discover neuroprotective role of immune cell 2International team sheds new light on biology underlying schizophrenia 2International team sheds new light on biology underlying schizophrenia 3
... brain assigns cells to participate in encoding and storing memories. ... a protein called CREB controls the odds of a neuron ... edition of Science reports the findings, which suggest a new ... other brain injury. , "Making a memory ...
... 2007, issue of the journal Neuron, published by Cell ... numerical information--both abstract quantities and their concrete representations as ... understanding how the brain processes quantitative information as well ... the brain develops in children. Such studies could aid ...
... protein protects human pancreatic cancer cells from being forced ... defenses against out-of-control cell growth, researchers at The University ... the March issue of Molecular Cancer Research. , The ... has been found by researchers at M. D. Anderson ...
Cached Biology News:UCLA/Toronto researchers unlock key to memory storage in brain 2Studies yield insight into the numerical brain 2Studies yield insight into the numerical brain 3Studies yield insight into the numerical brain 4Protein found to shield pancreatic cancer cells from self-destruction 2
... Clone/PAD: ZMD.257. Immunogen: Synthetic peptide derived ... human Connexin 36 protein This peptide ... to generate another Zymed polyclonal Connexin 36 ... with mouse Connexin 36. Reactivity: Mouse ...
Invitrogen's Calcium Phosphate Transfection Kit provides high-quality reagents to enable the introduction of DNA into tissue culture cells via calcium phosphate co-precipitation....
Biology Products: